… between immune responses and COVID-19, immune characteristics are now … therapeutic
targets for COVID-19. In this review, we summarize the immune characteristics of COVID-19 …

… novel Coronavirus disease 2019 (COVID-19). For this reason, many researchers have tried
to implement therapies to mitigate the cytokine storm in the treatment of COVID-19 patients, …

… In conclusion, the treatment strategy for patients with COVID-19 should be carefully designed
based on both viral kinetics and immunopathogenesis. However, pandemic infection with …

… therapeutic role of extracorporeal cytokine removal to treat the cytokine storm associated
with COVID-19. … in COVID-19, this study provides a possible therapeutic approach to treating …

… immunopathogenesis of SARS-CoV-2 in humans and to provide insight into more effective
therapeutic … Here, we describe the immune responses and immunopathogenesis of COVID-19…

… potently active during the immunopathogenic ARDS phase of COVID-19 disease, suggesting
that … A number of drugs and combinational therapies have been identified using previously …

… formulate theories and suggest possible therapeutic interventions. SARS-CoV2
immunopathogenic mechanisms vary from … Ultimately therapeutic intervention will be phase …

… knowledge of COVID-19 immunopathogenesis is crucially … of patients with COVID-19
provide valuable information with … for the use of complement inhibition as therapy in COVID-19. …

… of immunopathogenesis of COVID-19 will help in designing suitable immune therapy for the
… In this review, we have discussed the pathogenesis and immunopathogenesis of COVID-19 …

… Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute respiratory
syndrome coronavirus… of COVID-19 is important in developing effective therapies as well as …